I dont know about you, but it seems in study after study, the feedback from patients is much the same when it comes to the challenges of patient compliance: they forget, they feel better and so they cease taking their medication, they arent convinced the medication is actually helping them, so they stop taking it and so on. These are difficult challenges to overcome and the solutions for addressing them vary so much by patient population and disease therapy, that I think sometimes were so overwhelmed that we simply give up trying.
A survey conducted by AstraZeneca in 2008 among more than 7,800 patients online and reported by a speaker at a recent eyeforpharma conference brought more of what weve become accustomed to hearing from patients:
Perhaps most interestingly, however, in one of the strongest overall responses to this AstraZeneca survey, 57% of respondents said they would not take their medication unless they completely understood why they needed it. This is a question I havent seen patients asked quite so directly before. I would argue that its the $64,000 question of patient compliance really.
And surely this statistic explains all of the others. Because if you look closely at the other issues outlined here, they are ones that perhaps pharmas and even physicians have somewhat limited ability to influence of improve. But helping patients to understand why they need a given medication falls squarely on doctors and pharmas.
Its a good crystal ball look into what really impedes patients. Maybe by working on intelligent and comprehensive approaches to eliminating just this one barrier, we stand a much improved chance of fixing them all.
blog comments powered by DisqusOften criticised for not properly adopting new web technologies, pharma proves it knows a thing or two about the corporate website.
Jan Stojaspal explores the role of value-based pricing in gaining market access
Andrew Tolve explores how digital health coaching is helping the healthcare industry provide cost-effective services that boost adherence
Alex Gochtovtt, principal with Cognizant’s enterprise analytics practice, discusses pharma’s social media opportunities and the importance of data analytics
An interview with Serkan Erkovan of Boehringer Ingelheim.
Ashok Bhaseen, Vice President of Sales & Marketing at Pediapharm reveals how his company establishes trust when engaging KOLs